{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:03:19Z","timestamp":1784286199347,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["(grant no. 82160703)"],"award-info":[{"award-number":["(grant no. 82160703)"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004763","name":"Natural Science Foundation of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["2023LHMS08001, 2025MS08161, 2023QN08042, 2024QN08058"],"award-info":[{"award-number":["2023LHMS08001, 2025MS08161, 2023QN08042, 2024QN08058"]}],"id":[{"id":"10.13039\/501100004763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05607-w","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:34:05Z","timestamp":1781674445000},"page":"3177-3193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic effects of alprostadil on CCl4-induced hepatic fibrosis in rats and investigation of its molecular mechanisms"],"prefix":"10.1007","volume":"481","author":[{"given":"Ziqing","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"4","key":"5607_CR1","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","volume":"9","author":"N Roehlen","year":"2020","unstructured":"Roehlen N, Crouchet E, Baumert TF (2020) Hepatic fibrosis: mechanistic concepts and therapeutic perspectives. Cells 9(4):875","journal-title":"Cells"},{"key":"5607_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M (2019) Hepatic fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med 65:37\u201355","journal-title":"Mol Aspects Med"},{"issue":"2","key":"5607_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1535370219898141","volume":"245","author":"D Dhar","year":"2020","unstructured":"Dhar D, Baglieri J, Kisseleva T, Brenner DA (2020) Mechanisms of hepatic fibrosis and its role in liver cancer. Exp Biol Med 245(2):96\u2013108","journal-title":"Exp Biol Med"},{"key":"5607_CR4","doi-asserted-by":"publisher","first-page":"111572","DOI":"10.1016\/j.mad.2021.111572","volume":"199","author":"M Zhang","year":"2021","unstructured":"Zhang M, Serna-Salas S, Damba T, Borghesan M, Demaria M, Moshage H (2021) Hepatic stellate cell senescence in hepatic fibrosis: characteristics, mechanisms and perspectives. Mech Ageing Dev 199:111572","journal-title":"Mech Ageing Dev"},{"key":"5607_CR5","doi-asserted-by":"publisher","first-page":"867940","DOI":"10.3389\/fendo.2022.867940","volume":"13","author":"JK Carter","year":"2022","unstructured":"Carter JK, Friedman SL (2022) Hepatic stellate cell\u2013immune interactions in NASH. Front Endocrinol 13:867940","journal-title":"Front Endocrinol"},{"key":"5607_CR6","doi-asserted-by":"publisher","first-page":"217243","DOI":"10.1016\/j.canlet.2024.217243","volume":"604","author":"Y Yu","year":"2024","unstructured":"Yu Y, Li Y, Zhou L, Cheng X, Gong Z (2024) Hepatic stellate cells promote hepatocellular carcinoma development by regulating histone lactylation. Cancer Lett 604:217243","journal-title":"Cancer Lett"},{"key":"5607_CR7","doi-asserted-by":"publisher","first-page":"154626","DOI":"10.1016\/j.phymed.2022.154626","volume":"110","author":"C Chen","year":"2023","unstructured":"Chen C, Chen J, Wang Y, Fang L, Guo C, Sang T, Wang Y, Meng Q, Luo X, Li Z (2023) Ganoderma lucidum polysaccharide inhibits HSC activation and hepatic fibrosis via TGF-\u03b2\/Smad signaling. Phytomedicine 110:154626","journal-title":"Phytomedicine"},{"key":"5607_CR8","doi-asserted-by":"publisher","first-page":"156047","DOI":"10.1016\/j.phymed.2024.156047","volume":"135","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Ran T, Li S, Han L, Chen S, Lin G, Li J, Wang Y, Xu P, Fang X (2024) Catalpol ameliorates hepatic fibrosis via EphA2\/FAK\/Src signaling. Phytomedicine 135:156047","journal-title":"Phytomedicine"},{"key":"5607_CR9","doi-asserted-by":"publisher","first-page":"13473","DOI":"10.1038\/s41598-024-63644-1","volume":"14","author":"RM Wahid","year":"2024","unstructured":"Wahid RM, Hassan NH, Samy W, Abdelhadi AA, Saadawy SF, Elsayed SF, Mohamed A, Rashad A, Elshazly M, Farid M (2024) Hepatic stellate cell-mediated mechanisms in aging-related fibrosis. Sci Rep 14:13473","journal-title":"Sci Rep"},{"issue":"10","key":"5607_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101433","volume":"10","author":"M Elnagdy","year":"2020","unstructured":"Elnagdy M, Barve S, McClain C, Gobejishvili L (2020) cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease. Biomolecules 10(10):1433","journal-title":"Biomolecules"},{"issue":"6","key":"5607_CR11","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1097\/HEP.0000000000000333","volume":"78","author":"T Hong","year":"2023","unstructured":"Hong T, Xiong X, Chen Y, Wang Q, Fu X, Meng Q, Wang J, Li X, Zhao Y, Sun Y (2023) PTH1R signaling aggravates hepatic fibrosis through CREB-like 2. Hepatology 78(6):1763\u20131776","journal-title":"Hepatology"},{"issue":"11","key":"5607_CR12","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ebiom.2015.10.010","volume":"2","author":"Y Osawa","year":"2015","unstructured":"Osawa Y, Oboki K, Imamura J, Kojika E, Hayashi Y, Hishima T, Ishida Y, Murata T, Saito H, Koyama Y (2015) Inhibition of CBP\/\u03b2-catenin reduces hepatic fibrosis. EBioMedicine 2(11):1751\u20131758","journal-title":"EBioMedicine"},{"issue":"5","key":"5607_CR13","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1248\/bpb.b16-00947","volume":"40","author":"M Yamaguchi","year":"2017","unstructured":"Yamaguchi M, Saito SY, Nishiyama R, Nakamura M, Todoroki K, Toyo\u2019oka T, Watanabe E (2017) Caffeine suppresses HSC activation by antagonizing adenosine receptors independent of cAMP. Biol Pharm Bull 40(5):658\u2013664","journal-title":"Biol Pharm Bull"},{"key":"5607_CR14","doi-asserted-by":"publisher","first-page":"1730255","DOI":"10.3389\/fphar.2025.1730255","volume":"16","author":"J Xu","year":"2025","unstructured":"Xu J, Sang X, He Y, Ke J, Xu J, Liu T, Zhang Y, Wang Y, Shi L, Chen J (2025) Lycii radicis cortex alleviates fibrosis via the cAMP\u2013PKA pathway. Front Pharmacol 16:1730255","journal-title":"Front Pharmacol"},{"issue":"5","key":"5607_CR15","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1084\/jem.20142235","volume":"212","author":"MF Diaz","year":"2015","unstructured":"Diaz MF, Li N, Lee HJ, Adamo L, Evans SM, Willey HE, Arora R, Torregrosa JM, Young C, Keller GM (2015) Biomechanical forces promote blood development through PGE2\/cAMP\u2013PKA signaling. J Exp Med 212(5):665\u2013680","journal-title":"J Exp Med"},{"issue":"5","key":"5607_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1139\/cjpp-2015-0437","volume":"94","author":"Y Yang","year":"2016","unstructured":"Yang Y, Yang F, Wu X, Lv X, Li J (2016) EPAC activation inhibits acetaldehyde-induced HSC activation via Rap1. Can J Physiol Pharmacol 94(5):498\u2013507","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"5607_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/path.6194","volume":"261","author":"M Elnagdy","year":"2023","unstructured":"Elnagdy M, Wang Y, Rodriguez W, Zhang J, Bauer P, Wilkey DW, Brown K, Shobair M, Patel J, Gobejishvili L (2023) Increased PDE4 promotes HSC cytoskeleton remodeling and migration. J Pathol 261(3):361\u2013371","journal-title":"J Pathol"},{"issue":"24","key":"5607_CR18","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3390\/cells14241992","volume":"14","author":"H Tsuchiya","year":"2025","unstructured":"Tsuchiya H, Hanaki T, Yoshida J, Obora M, Fujiwara Y, Nanba D (2025) PGE1 suppresses M2 macrophage markers. Cells 14(24):1992","journal-title":"Cells"},{"issue":"4","key":"5607_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.5500\/wjt.v14.i4.98797","volume":"14","author":"V Jahagirdar","year":"2024","unstructured":"Jahagirdar V, Ahmed M, Fatima I, Ali H, Alba L, Helzberg JH, Patel K, Kumar R, Singh S, Dahiya D (2024) Prostaglandin E1 post liver transplantation and renal outcomes. World J Transpl 14(4):987\u2013997","journal-title":"World J Transpl"},{"issue":"2","key":"5607_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s003950170069","volume":"96","author":"U Marienfeld","year":"2001","unstructured":"Marienfeld U, Walter U, Simm A (2001) cAMP- but not cGMP-dependent kinase inhibits cardiac fibroblast growth. Basic Res Cardiol 96(2):184\u2013191","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"5607_CR21","doi-asserted-by":"publisher","first-page":"e230153","DOI":"10.1530\/JME-23-0153","volume":"73","author":"AR Walker","year":"2024","unstructured":"Walker AR, Parkin HA, Kim SH, Terzidou V, Woodward DF, Bennett PR, Thornton S, Lee Y, Chan SY, Johnson MR (2024) Constitutive EP2 internalization regulates G protein signaling. J Mol Endocrinol 73(1):e230153","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"5607_CR22","first-page":"176","volume":"6","author":"WL Zou","year":"2007","unstructured":"Zou WL, Yang Z, Zang YJ, Li DJ, Liang ZP, Shen ZY (2007) PGE1 inhibits HSC activation in schistosomiasis. Hepatobiliary Pancreat Dis Int 6(2):176\u2013181","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"4","key":"5607_CR23","first-page":"S523","volume":"66","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Wang L, Chen X et al (2017) Alprostadil alleviates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting hepatic stellate cell activation. J Hepatol 66(4):S523\u2013S524","journal-title":"J Hepatol"},{"key":"5607_CR24","doi-asserted-by":"crossref","first-page":"173382","DOI":"10.1016\/j.ejphar.2020.173382","volume":"883","author":"H Yang","year":"2020","unstructured":"Yang H, Liu T, Xu J et al (2020) Prostaglandin E1 improves liver function and attenuates fibrosis in a rat model of nonalcoholic steatohepatitis. Eur J Pharmacol 883:173382","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"5607_CR25","first-page":"1098","volume":"508","author":"R Han","year":"2019","unstructured":"Han R, Li L, Zhang R et al (2019) The cAMP\/PKA\/CREB pathway regulates the expression of GRP78 to prevent endoplasmic reticulum stress-induced apoptosis in hepatocytes. Biochem Biophys Res Commun 508(4):1098\u20131104","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"5607_CR26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41419-021-03833-2","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang J, Sun Y, Xu F et al (2021) EPAC1 deficiency ameliorates hepatic fibrosis by suppressing hepatic stellate cell activation via the Rap1\/JNK pathway. Cell Death Dis 12(6):564","journal-title":"Cell Death Dis"},{"issue":"2","key":"5607_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","volume":"10","author":"I Mederacke","year":"2015","unstructured":"Mederacke I, Dapito DH, Aff\u00f2 S, Uchinami H, Schwabe RF (2015) High-purity isolation of hepatic stellate cells. Nat Protoc 10(2):305\u2013315","journal-title":"Nat Protoc"},{"issue":"9","key":"5607_CR28","first-page":"1257","volume":"37","author":"YF Shi","year":"2017","unstructured":"Shi YF et al (2017) TGF-\u03b21-induces activation of HSC-T6 cells and epithelial-mesenchymal transition in rats. Basic Clin Med 37(9):1257\u20131262","journal-title":"Basic Clin Med"},{"key":"5607_CR29","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.7445","author":"YB Liu","year":"2017","unstructured":"Liu YB et al (2017) Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF-\u03b21\/Smad3 signaling pathway. Molecular Medicine Reports. https:\/\/doi.org\/10.3892\/mmr.2017.7445","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"5607_CR30","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1038\/s41598-017-04317-0","volume":"7","author":"Y Zhao","year":"2017","unstructured":"Zhao Y et al (2017) Focal adhesion kinase regulates hepatic stellate cell activation and liver fibrosis. Sci Rep 7(1):4032","journal-title":"Sci Rep"},{"key":"5607_CR31","unstructured":"Malik K, Nicolas S, Dua A (2025) In: StatPearls (ed) Prostaglandins. StatPearls Publishing, Treasure Island (FL)"},{"issue":"Suppl 8","key":"5607_CR32","first-page":"14","volume":"63","author":"H Shio","year":"2005","unstructured":"Shio H (2005) Prostaglandin E1, E2 and metabolites. Nihon Rinsho 63(Suppl 8):14\u201316","journal-title":"Nihon Rinsho"},{"issue":"2","key":"5607_CR33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1017\/S1047951123001403","volume":"34","author":"JL Col\u00edn Ortiz","year":"2024","unstructured":"Col\u00edn Ortiz JL, Cruz Hern\u00e1ndez A, Silva Estrada JA, Maldonado Alonso R, Corona Villalobos CA, Gonz\u00e1lez Rebeles Guerrero C (2024) L\u00f3pez C\u00e1rdenas A, P\u00e9rez Gonz\u00e1lez L, Rojas Mart\u00ednez R, Hern\u00e1ndez Garc\u00eda R. Intravenous PGE1 bolus in ductus arteriosus-dependent CHD. Cardiol Young 34(2):314\u2013318","journal-title":"Cardiol Young"},{"issue":"3","key":"5607_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/21548331.2022.2072314","volume":"50","author":"A Machanahalli Balakrishna","year":"2022","unstructured":"Machanahalli Balakrishna A, Ismayl M, Butt DN, Niu F, Latif A, Arouni AJ, Alghamdi ZS, Alnahdi W, Hassan MA, Al-Khatib SM (2022) Acute myocardial infarction in chronic viral hepatitis. Hosp Pract 50(3):236\u2013243","journal-title":"Hosp Pract"},{"key":"5607_CR35","first-page":"3812424","volume":"2018","author":"F Xu","year":"2018","unstructured":"Xu F, Liu X, Wang C, Dai C (2018) PGE1 preconditioning attenuates liver ischemia\/reperfusion injury. Biomed Res Int 2018:3812424","journal-title":"Biomed Res Int"},{"issue":"40","key":"5607_CR36","doi-asserted-by":"publisher","first-page":"7253","DOI":"10.3748\/wjg.v23.i40.7253","volume":"23","author":"FW Yang","year":"2017","unstructured":"Yang FW, Fu Y, Li Y, He YH, Mu MY, Liu QC, Wang H, Chen J, Zhang S, Li X (2017) PGE1 protects hepatocytes via PKA-dependent GRP78 induction. World J Gastroenterol 23(40):7253\u20137264","journal-title":"World J Gastroenterol"},{"issue":"13","key":"5607_CR37","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1158\/0008-5472.CAN-19-2052","volume":"80","author":"F Wu","year":"2020","unstructured":"Wu F, Zhang C, Zhao C, Wu H, Teng Z, Jiang T, Li J, Wang X, Chen Q, Zhou Y (2020) PGE1 inhibits GLI2-driven Hedgehog activation. Cancer Res 80(13):2818\u20132832","journal-title":"Cancer Res"},{"issue":"1","key":"5607_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000504173","volume":"117","author":"V Palma-Barqueros","year":"2020","unstructured":"Palma-Barqueros V, Torregrosa JM, Caparr\u00f3s-P\u00e9rez E, Mota-P\u00e9rez N, Bohdan N, Llanos MDC, Garc\u00eda C, Mart\u00ednez L, Llor\u00e9ns C, S\u00e1nchez G (2020) Developmental differences in platelet inhibition by PGE1. Neonatology 117(1):15\u201323","journal-title":"Neonatology"},{"key":"5607_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.yjmcc.2025.11.013","volume":"211","author":"MM Hulsurkar","year":"2025","unstructured":"Hulsurkar MM, Ong I, Keefe JA, Abu-Taha IH, Dobrev D, Wehrens XHT (2025) cAMP regulation of ryanodine receptors. J Mol Cell Cardiol 211:53\u201362","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"5607_CR40","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","volume":"132","author":"TV Masyuk","year":"2007","unstructured":"Masyuk TV, Masyuk AI, Torres VE, Harris PC, Larusso NF (2007) Octreotide reduces cAMP and inhibits hepatic cystogenesis. Gastroenterology 132(3):1104\u20131116","journal-title":"Gastroenterology"},{"key":"5607_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.lfs.2019.03.014","volume":"222","author":"RM Essam","year":"2019","unstructured":"Essam RM, Ahmed LA, Abdelsalam RM, El-Khatib AS (2019) PDE1\/4 inhibitors ameliorate hepatic fibrosis via cAMP\/CREB\/TLR4 modulation. Life Sci 222:245\u2013254","journal-title":"Life Sci"},{"issue":"5","key":"5607_CR42","doi-asserted-by":"crossref","first-page":"e0216301","DOI":"10.1371\/journal.pone.0216301","volume":"14","author":"SA El Awdan","year":"2019","unstructured":"El Awdan SA, Abdel Rahman RF, Ibrahim HM, Hegazy RR, El Marasy SA, Badawi M, El-Bakly WM, Ahmed MM, Henry MA, Mosli HH (2019) Cilostazol regresses fibrosis via cAMP modulation. PLoS ONE 14(5):e0216301","journal-title":"PLoS ONE"},{"issue":"9","key":"5607_CR43","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1021\/jm401425e","volume":"57","author":"H Chen","year":"2014","unstructured":"Chen H, Wild C, Zhou X, Ye N, Cheng X, Zhou J (2014) Advances in small molecules targeting EPAC. J Med Chem 57(9):3651\u20133656","journal-title":"J Med Chem"},{"key":"5607_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1937-6448(10)83005-9","volume":"283","author":"P Skroblin","year":"2010","unstructured":"Skroblin P, Grossmann S, Sch\u00e4fer G, Rosenthal W, Klussmann E (2010) Mechanisms of PKA anchoring. Int Rev Cell Mol Biol 283:235\u2013330","journal-title":"Int Rev Cell Mol Biol"},{"issue":"5","key":"5607_CR45","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1210\/me.2008-0204","volume":"23","author":"JP Vilardaga","year":"2009","unstructured":"Vilardaga JP, B\u00fcnemann M, Feinstein TN, Lambert N, Nikolaev VO, Engelhardt S, Lohse MJ, Hoffmann C, Conklin BR, Kobilka BK (2009) GPCR\/G protein signaling in live cells. Mol Endocrinol 23(5):590\u2013599","journal-title":"Mol Endocrinol"},{"issue":"1","key":"5607_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1476-5381.2009.00185.x","volume":"158","author":"M Zaccolo","year":"2009","unstructured":"Zaccolo M (2009) Spatial control of cAMP signaling in the heart. Br J Pharmacol 158(1):50\u201360","journal-title":"Br J Pharmacol"},{"key":"5607_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbrc.2021.12.040","volume":"588","author":"J Yu","year":"2022","unstructured":"Yu J, Zhu J, Deng J, Shen J, Du F, Wu X, Zhang H, Liu Y, Chen Y, Li M (2022) Dopamine receptor D1 stimulates lipolysis via cAMP. Biochem Biophys Res Commun 588:83\u201389","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5607_CR48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1124\/jpet.113.207001","volume":"348","author":"C Vettel","year":"2014","unstructured":"Vettel C, Hottenrott MC, Spindler R, Benck U, Schnuelle P, Tsagogiorgas C, Ritter O, Dihazi H, Schreiber Y, Kaden J (2014) Dopamine protects cardiomyocytes against cold injury. J Pharmacol Exp Ther 348(1):77\u201385","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"5607_CR49","doi-asserted-by":"publisher","first-page":"e0216301","DOI":"10.1371\/journal.pone.0216301","volume":"14","author":"NM Elsherbiny","year":"2019","unstructured":"Elsherbiny NM, El-Sherbiny M, Said E et al (2019) Regression of fibrosis by cilostazol in a rat model of thioacetamide-induced liver fibrosis: Up regulation of hepatic cAMP, and modulation of inflammatory, oxidative stress and apoptotic biomarkers. PLoS ONE 14(5):e0216301","journal-title":"PLoS ONE"},{"key":"5607_CR50","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41467-025-67994-w","volume":"17","author":"X Huang","year":"2026","unstructured":"Huang X, Liang S, Zhao N, Zhang X, Liu Y, Wang H, Chen J, Li W, Hu X (2026) Hepatocyte SLCO4C1 is a cAMP uptake transporter for inhibiting lipogenesis and a therapeutic target for MASLD. Nat Commun 17:1234","journal-title":"Nat Commun"},{"key":"5607_CR51","doi-asserted-by":"publisher","first-page":"100779","DOI":"10.1016\/j.cophys.2024.100779","volume":"41","author":"S von Marden","year":"2024","unstructured":"von Marden S, Paige P, Schulz R (2024) The two-sided impact of beta-adrenergic receptor ligands on inflammation. Curr Opin Physiol 41:100779","journal-title":"Curr Opin Physiol"},{"key":"5607_CR52","first-page":"97","volume":"48","author":"DA Rodrigues","year":"2018","unstructured":"Rodrigues DA, Pinheiro AR, Varela CL et al (2018) Role of cAMP and phosphodiesterase signaling in liver health and disease. Cell Signal 48:97\u2013111","journal-title":"Cell Signal"},{"issue":"11","key":"5607_CR53","first-page":"2601","volume":"238","author":"S El Nagdy","year":"2023","unstructured":"El Nagdy S, Abdel Ghany E, El Gayar A et al (2023) Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration. J Cell Physiol 238(11):2601\u20132615","journal-title":"J Cell Physiol"},{"key":"5607_CR54","first-page":"55","volume":"20","author":"SK Hegazy","year":"2019","unstructured":"Hegazy SK, El-Sayed EM, Abdel-Ghany SE (2019) Phosphodiesterase 4 inhibitors: a new frontier in the treatment of liver fibrosis? J Adv Res 20:55\u201364","journal-title":"J Adv Res"},{"issue":"5","key":"5607_CR55","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1042\/BST20190230","volume":"47","author":"MG Gold","year":"2019","unstructured":"Gold MG (2019) Swimming regulations for protein kinase A catalytic subunit. Biochem Soc Trans 47(5):1355\u20131366","journal-title":"Biochem Soc Trans"},{"key":"5607_CR56","unstructured":"Xiong WH, Qin M, Zhong H (2024) PKA catalytic\u2013regulatory dissociation regulates neuronal function. bioRxiv. ;2023.09.05.556437."},{"key":"5607_CR57","doi-asserted-by":"publisher","first-page":"120650","DOI":"10.1016\/j.jep.2025.120650","volume":"355","author":"R Zeng","year":"2026","unstructured":"Zeng R, Guo Y, Qi J, Li M, Huang K, Peng Y, Wang Z, Ren L, Su Y, Chen Y (2026) Dantao formula alleviates hepatic fibrosis via cAMP\/PKA\/ROCK signaling. J Ethnopharmacol 355:120650","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"5607_CR58","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1002\/fsn3.1709","volume":"8","author":"E Yoshikawa","year":"2020","unstructured":"Yoshikawa E, Matsui-Yuasa I, Huang X, Kobayashi Y, Kojima-Yuasa A (2020) Mallotus furetianus protects against ethanol-induced liver injury via cAMP\u2013PKA activation. Food Sci Nutr 8(7):3936\u20133946","journal-title":"Food Sci Nutr"},{"issue":"45","key":"5607_CR59","doi-asserted-by":"publisher","first-page":"18613","DOI":"10.1073\/pnas.1210209109","volume":"109","author":"T Tsalkova","year":"2012","unstructured":"Tsalkova T, Mei FC, Li S, Chepurny OG, Leech CA, Liu T, Holz GG, Woods VL, Taylor SS, Cheng X (2012) Isoform-specific EPAC antagonists. Proc Natl Acad Sci U S A 109(45):18613\u201318618","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5607_CR60","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbrc.2017.10.142","volume":"495","author":"H Ichikawa","year":"2018","unstructured":"Ichikawa H, Itsumi M, Kajioka S, Maki T, Lee K, Tomita M, Matsunaga S, Ito H, Nagata K, Sasaki T (2018) EPAC1 overexpression attenuates bladder cancer migration. Biochem Biophys Res Commun 495(1):64\u201370","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"5607_CR61","first-page":"2381","volume":"17","author":"K Han","year":"2019","unstructured":"Han K, Zhang Y, Yang Z (2019) Cilostazol protects against alcohol-induced hepatic fibrosis via cAMP\/Epac1. Exp Ther Med 17(3):2381\u20132388","journal-title":"Exp Ther Med"},{"key":"5607_CR62","doi-asserted-by":"publisher","first-page":"119506","DOI":"10.1016\/j.jep.2025.119506","volume":"344","author":"YY Yang","year":"2025","unstructured":"Yang YY, Gong NC, Peng YM, Yang ZS, Xiang DX (2025) Manshenkang granules alleviate fibrosis via PDE4b\/cAMP modulation. J Ethnopharmacol 344:119506","journal-title":"J Ethnopharmacol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05607-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05607-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05607-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:04:33Z","timestamp":1784282673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05607-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":62,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["5607"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05607-w","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Animal Ethics Committee of Inner Mongolia Medical University (approval No. YKD202501047).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}